Brawn Biotech Ltd vs Samrat Pharmachem Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 05, 2026

Key Highlights

The Latest Trading Price of Brawn Biotech Ltd is ₹ 20.8 as of 04 May 15:30 . The P/E Ratio of Brawn Biotech Ltd changed from 0 on March 2021 to 0 on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe P/E Ratio of Samrat Pharmachem Ltd changed from 7.9 on March 2021 to 13.6 on March 2025 . This represents a CAGR of 11.48% over 5 years The Market Cap of Brawn Biotech Ltd changed from ₹ 6.63 crore on March 2021 to ₹ 4.88 crore on March 2025 . This represents a CAGR of -5.95% over 5 yearsThe Market Cap of Samrat Pharmachem Ltd changed from ₹ 42.02 crore on March 2021 to ₹ 96.63 crore on March 2025 . This represents a CAGR of 18.12% over 5 years The revenue of Brawn Biotech Ltd for the Dec '25 is ₹ 4.4 crore as compare to the Sep '25 revenue of ₹ 4.98 crore. This represent the decline of -11.65% The revenue of Samrat Pharmachem Ltd for the Dec '25 is ₹ 63.83 crore as compare to the Sep '25 revenue of ₹ 78.92 crore. This represent the decline of -19.12% The ebitda of Brawn Biotech Ltd for the Dec '25 is ₹ 0.08 crore as compare to the Sep '25 ebitda of ₹ 0.1 crore. This represent the decline of -20% The ebitda of Samrat Pharmachem Ltd for the Dec '25 is ₹ -0.26 crore as compare to the Sep '25 ebitda of ₹ -0.31 crore. This represent the decline of -16.13% The net profit of Brawn Biotech Ltd changed from ₹ -0.53 crore to ₹ 0.05 crore over 7 quarters. This represents a CAGR of NaN% The net profit of Samrat Pharmachem Ltd changed from ₹ 2.07 crore to ₹ -0.46 crore over 7 quarters. This represents a CAGR of NaN% The Dividend Payout of Brawn Biotech Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Samrat Pharmachem Ltd changed from 1.8 % on March 2022 to 4.35 % on March 2025 . This represents a CAGR of 24.68% over 4 years .

About Brawn Biotech Ltd

Brawn Biotech Limited was originally incorporated in the name of Brawn Pharmaceuticals Limited in November, 1985.
Thereafter, the name of the Company was changed from Brawn Pharmaceuticals Limited to Brawn Biotech Limited in November, 2010.
Brawn, with its inception barely 38 years back has today evolved into a fully integrated, healthcare group, marking its presence in India and across the globe. The Company possess product registration with major health and govt. institutions throughout India and worldwide.
Headed and represented by a team of skilled industry experts with impressive educational backgrounds and broad experience, the Company has spread its wings in expansion in the domestic as well as in the international markets beyond the existing horizon to stand among the leading Indian HealthCare products distribution Companies.

About Samrat Pharmachem Ltd

Samrat Pharmachem Limited was incorporated on June 16, 1992 at Ankleshwar in Gujarat led by the Promoters, Mr. Lalit Mehta & Mr. Rajesh Mehta.
Since then, it envisioned to focus on lodine Derivatives as their core products.
The Company's principal activities are manufacturing and selling chemicals.
Company is a producer of pharmaceutical chemicals.
The intermediates produced are used in pharmaceutical and chemical industries.

FAQs for the comparison of Brawn Biotech Ltd and Samrat Pharmachem Ltd

Which company has a larger market capitalization, Brawn Biotech Ltd or Samrat Pharmachem Ltd?

Market cap of Brawn Biotech Ltd is 5 Cr while Market cap of Samrat Pharmachem Ltd is 65 Cr

What are the key factors driving the stock performance of Brawn Biotech Ltd and Samrat Pharmachem Ltd?

The stock performance of Brawn Biotech Ltd and Samrat Pharmachem Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Brawn Biotech Ltd and Samrat Pharmachem Ltd?

As of May 5, 2026, the Brawn Biotech Ltd stock price is INR ₹19.0. On the other hand, Samrat Pharmachem Ltd stock price is INR ₹213.3.

How do dividend payouts of Brawn Biotech Ltd and Samrat Pharmachem Ltd compare?

To compare the dividend payouts of Brawn Biotech Ltd and Samrat Pharmachem Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.